Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Pacific News Journal.
Press releases published on April 28, 2025
Endpoint Detection and Response (EDR) Market Size to Reach $22.00 Bn by 2031 Globally, at 25.9% CAGR: The Insight Partners
GlobeNewswire
·
April 28, 2025
US …
Smart Share Global Limited Files Its Annual Report on Form 20-F
GlobeNewswire
·
April 28, 2025
SHANGHAI, April 28, 2025 (GLOBE NEWSWIRE) -- Smart Share Global Limited (Nasdaq: EM) (“Energy Monster” or the “Company”), a consumer tech company providing mobile device charging service, today announced that it filed its annual report on Form 20-F for the …
Evoq Technologies Corp. Breakthroughs at ARVO 2025: 'Turning the Unbearable Into a Comfortable Wearable'
EIN Presswire
·
April 28, 2025
LAS VEGAS, NV, UNITED STATES, April 27, 2025 /EINPresswire.com/ -- Evoq Technologies is unveiling its latest scientific and diagnostic innovations at ARVO 2025, introducing a new generation of wearable devices designed to detect disease earlier and …
Radiopharm Theranostics Doses First Patient with 18F-RAD101 in U.S. Phase 2b Imaging Study of Brain Metastasis
GlobeNewswire
·
April 28, 2025
Phase 2b study evaluating diagnostic performance of 18F-RAD101 for suspected recurrent brain metastases from solid tumors of different origins Underscores Radiopharm’s commitment to developing transformative oncology radiopharmaceuticals SYDNEY, April 28, …
Quanta Therapeutics Presents Late-Breaking Data for QTX3544, an Oral G12V-Preferring Multi-KRAS Inhibitor, at AACR Annual Meeting 2025
GlobeNewswire
·
April 28, 2025
- Preclinical data demonstrates synergy of QTX3544 with EGFR inhibitors, broadly enhancing anti-tumor activity - - Data supports ongoing Phase 1 clinical trial for QTX3544 as monotherapy and in combination with cetuximab in patients with KRASG12V mutations …
Adagene Appoints John Maraganore, Ph.D. as Executive Advisor
GlobeNewswire
·
April 28, 2025
- Biotech luminary to mentor C-suite and provide strategic guidance - SAN DIEGO and SUZHOU, China, April 28, 2025 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the discovery and development of antibody-based therapies, …
MicroAlgo Announces Strong Net Income and Cash Growth in 2024, Driven by Robust Demand for Central Processing Algorithm Services
GlobeNewswire
·
April 28, 2025
Shenzhen, April 28, 2025 (GLOBE NEWSWIRE) -- Shenzhen, China, April 28, 2025 – MicroAlgo Inc. (NASDAQ: MLGO), (the “Company”), a leading developer and application provider of bespoke central processing algorithms, today announced its financial results for …
MMA.inc Partners with Brazilian Jiu-Jitsu Icon Clark Gracie: Accelerates BJJLink Expansion and Unlocks Potential New Revenue Streams Across Over 5,700 New Students
GlobeNewswire
·
April 28, 2025
Key Highlights Clark Gracie renowned Brazilian Jiu-Jitsu champion and grandson of Carlos Gracie, the founder of modern Jiu-Jitsu. Unlocks potential new revenue streams across key U.S. regions and international markets, with Gracie Allegiance affiliates …
ICT Adoption in Aerospace & Defense Set to Accelerate, Projected to Grow at 5.8% CAGR by 2030
GlobeNewswire
·
April 28, 2025
Middleton, Massachusetts, April 28, 2025 (GLOBE NEWSWIRE) -- QKS Group, a premier market intelligence and advisory firm, has released its latest vertical-specific research highlighting the growing role of Information and Communication Technology (ICT) in …
Silo Pharma Expands Intellectual Property Portfolio with Patent Application for Exclusively Licensed Alzheimer’s Drug
GlobeNewswire
·
April 28, 2025
SARASOTA, FL, April 28, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced the filing of a patent …
Alterity Therapeutics Presents ATH434-201 Phase 2 Clinical Trial Results at European MSA Symposium
GlobeNewswire
·
April 28, 2025
MELBOURNE, Australia and SAN FRANCISCO, April 28, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative …
Guardforce AI Reports Full-Year 2024 Financial Results and Provides Business Update
GlobeNewswire
·
April 28, 2025
Gross profit increased 16.1% in 2024 compared to 2023 Building a robust AI technology foundation to drive solution development in travel and retail Guardforce AI management to host conference call today at 8:30 AM ET NEW YORK, April 28, 2025 (GLOBE …
Chengdu Will Mark 100-day Countdown to TWG 2025 Chengdu
GlobeNewswire
·
April 28, 2025
CHENGDU, China, April 28, 2025 (GLOBE NEWSWIRE) -- On April 29, on the eve of International Workers' Day, the countdown to the TWG 2025 Chengdu will reach the critical 100-day mark. Chengdu, the host city, is welcoming the upcoming The World Games 2025 …
EBC Financial Group Deepens Commitment to United to Beat Malaria with Renewed Global Partnership and First-Ever 5K Run Sponsorship
GlobeNewswire
·
April 28, 2025
WASHINGTON, April 28, 2025 (GLOBE NEWSWIRE) -- As the world marks World Malaria Day 2025 under the theme “Malaria Ends With Us: Reinvest, Reimagine, Reignite,” EBC Financial Group (EBC) is renewing its global partnership with the United Nations Foundation’ …
BPGbio CEO Dr. Niven R. Narain Named to The Medicine Maker Power List 2025
GlobeNewswire
·
April 28, 2025
BOSTON, April 28, 2025 (GLOBE NEWSWIRE) -- BPGbio, Inc., a biology-first, AI-powered clinical-stage biopharma company, today announced that President and CEO Niven R. Narain, Ph.D. has been named to The Medicine Maker’s Power List 2025. The annual list …
Hudbay’s Eugene Lei wins Globe and Mail’s Report on Business 2025 Best Executive Award
GlobeNewswire
·
April 28, 2025
TORONTO, April 28, 2025 (GLOBE NEWSWIRE) -- Hudbay Minerals Inc. (“Hudbay” or the “Company”) (TSX, NYSE: HBM) is pleased to announce that Eugene Lei, Chief Financial Officer at Hudbay, has been recognized as a winner of the Globe and Mail’s Report on …
Kandi Technologies Reports 2024 Financial Results
GlobeNewswire
·
April 28, 2025
Revenue Of $127.6M up 3.2% YoY, Supported by Expanded Product Reach And Improved Geographic Balance Electric Off-Road Vehicle Revenue Rose 8.9% YoY, Reinforcing Core Segment Leadership Enhanced Supply Chain Flexibility with Taiwan Upgrades, While …
Neumora Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025
GlobeNewswire
·
April 28, 2025
WATERTOWN, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of seven brain disease programs including two clinical-stage programs, today …
Arvinas to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025
GlobeNewswire
·
April 28, 2025
NEW HAVEN, Conn., April 28, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company working to develop a new class of drugs based on targeted protein degradation, today announced that management will review first …
Ampersand Biomedicines Presents Preclinical Data on AMP-410, a Novel Anti-VEGF/4-1BB Bifunctional AND-Body™ Therapeutic, at AACR 2025
GlobeNewswire
·
April 28, 2025
Lead development candidate, AMP-410, leverages proprietary Ampersand technology to block VEGF and allosterically activate 4-1BB signaling – unlike traditional bispecific molecules – driving both adaptive and innate anti-tumor activity In multiple …